ScholarIQanswers from OpenAlex

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods

PaperCitations, authors & open-access status

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods have?

ScholarIQcitation count

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods has 23 citations in the OpenAlex counts ScholarIQ stores.

When was Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods published?

ScholarIQyear

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods has 2024 year in the ScholarIQ index.

What is the open-access status of Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods?

ScholarIQoa status

Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods has closed oa status in the ScholarIQ index.

What is the DOI of Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods?

ScholarIQdoi

The DOI for Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods is on the source record.

What is the PMID of Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods?

ScholarIQpmid

The PMID for Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods is on the source record.

What is the OpenAlex record for Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods?

ScholarIQopenalex

The OpenAlex for Rare SMARCA4-deficient thoracic tumor: Insights into molecular characterization and optimal therapeutics methods is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial